BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bioterrorism, Prostate Cancer And Menopause Among Topics At Michigan State Medical Society Annual Scientific Meeting


10/19/2005 5:10:17 PM

EAST LANSING, Mich., Nov. 5 /PRNewswire/ -- Michigan's preparedness for bioterrorism, disparities in the treatment of prostate cancer and a review of hormone replacement therapy will be among the 40 topics presented at the Michigan State Medical Society's 138th Annual Scientific Meeting (ASM) on Nov. 5-7 at the Somerset Inn in Troy.

"Bioterrorism, Chemical Terrorism and the State's Preparedness Efforts" will be presented from 8:30 a.m. to Noon on Thursday, Nov. 6. The state's leading experts in this area will cover hospital response to bioterrorism disasters and discuss possible contaminants including smallpox and monkeypox.

"Menopausal Medicine Update" will be presented from 1:30 to 5:30 p.m. on Thursday, Nov. 6. Topics will include the safety and efficacy of hormone replacement therapy (HRT), alternatives to HRT and a discussion of osteoporosis and cancers in the menopausal patient.

An "Early Bird" plenary session from 7 to 8 a.m. on Friday, Nov. 7, will review "Health Disparities in the Management of Prostate Cancer" focusing on prostate cancer in African-American men.

"For 138 years the Michigan State Medical Society has worked hard to keep its members up-to-date on new health care treatments and developments," said MSMS president Hassan Amirikia, MD, a Detroit obstetrician-gynecologist. "More than 600 physicians will attend these classes to continue their medical education to provide the very best health care for their patients."

Michigan State Medical Society

CONTACT: David Fox, Director, Public Relations of Michigan State MedicalSociety, +1-517-336-5731, or dkfox@msms.org



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES